Plasmon resonance coupling of metal nanoparticles for molecular imaging of carcinogenesis in vivo

  • Aaron J
  • Nitin N
  • Travis K
  • et al.
173Citations
Citations of this article
106Readers
Mendeley users who have this article in their library.

Abstract

An effective cancer control strategy requires improved early detection methods, patient-specific drug selection, and the ability to assess response to targeted therapeutics. Recently, plasmon resonance coupling between closely spaced metal nanoparticles has been used to develop ultrasensitive bioanalytical assays in vitro. We demonstrate the first in vivo application of plasmon coupling for molecular imaging of carcinogenesis. We describe molecular-specific gold bioconjugates to image epidermal growth factor receptor (EGFR); these conjugates can be delivered topically and imaged noninvasively in real time. We show that labeling with gold bioconjugates gives information on the overexpression and nanoscale spatial relationship of EGF receptors in cell membranes, both of which are altered in neoplasia. EGFR-mediated aggregation of gold nanoparticles in neoplastic cells results in more than a 100-nm color shift and a contrast ratio of more than tenfold in images of normal and precancerous epithelium in vivo, dramatically increasing contrast beyond values reported previously for antibody-targeted fluorescent dyes. © 2007 Society of Photo-Optical Instrumentation Engineers.

Cite

CITATION STYLE

APA

Aaron, J., Nitin, N., Travis, K., Kumar, S., Collier, T., Park, S. Y., … Sokolov, K. (2007). Plasmon resonance coupling of metal nanoparticles for molecular imaging of carcinogenesis in vivo. Journal of Biomedical Optics, 12(3), 034007. https://doi.org/10.1117/1.2737351

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free